AzurRx BioPharma, Inc.

AZRXNASDAQHealthcare

$3.45

+$0.07(+2.07%)

Market Cap$3432760

P/E Ratio—

52W High$3.66

52W Low$3.38

Avg Volume713K

Open$3.38

Beta1.51

Overview

AzurRx BioPharma, Inc. (AZRX) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

azrx · stock forecast · 4 analysts (3M) · FMP · updated Mar 14, 2024

Analyst Rating & Consensus

Based on 4 Wall Street analysts in the past 3 months

Buy

4 analysts

consensus

Rating Breakdown

Strong Buy

Buy

Hold

Sell

Strong Sell

Total: 4 · Buy rate: 100.0%

12-Month Price Target

High

$0.00

Consensus

$0.00

+0.0% upside

Low

$0.00

Median: $0 · Last Close: $3.45

The AzurRx BioPharma, Inc. (AZRX) analyst consensus is Buy, based on ratings from 4 Wall Street analysts over the past 3 months. The average 12-month AZRX price target is $0.00, representing +0.0% upside from the current price of $3.45.

Short-Term Price Prediction

Bear

Algorithmically generated · Updated daily

Date	Predicted Price	Change	Min	Max
2026-06-10	$3.28	↓ 5.00%	$3.21	$3.35

1-day model range: $3.21–$3.35. Peak: $3.35 (-5.00%).

Long-Term Stock Price Prediction

⚠️ Long-term projections are hidden until 252 trading days of history (IPO / limited listing). Short-term tab may still show model output.

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BEARISH

Based on 14 technical indicators

7%29%64%

1Buy

4Neutral

9Sell

RSI (14)18.6Oversold

MACDBEARISH

Refreshes daily from EOD close

Moving Averages · AZRX · Jun 9, 2026

Simple Moving Average (SMA)

MA 5$3.67SELL

MA 10$4.50SELL

MA 20$5.38SELL

MA 50$5.85SELL

MA 100$0.00NEUTRAL

MA 200$0.00NEUTRAL

Current $AZRX · Price above MA = BUY signal

Exponential Moving Average (EMA)

EMA 5$3.76SELL

EMA 10$4.32SELL

EMA 20$4.96SELL

EMA 50$5.96SELL

EMA 100$0.00NEUTRAL

EMA 200$0.00NEUTRAL

Current $AZRX · Price above MA = BUY signal

How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:

Date	Brokerage	Action	Rating
2021-08-02	HC Wainwright & Co.	Maintains	Buy→Buy
2021-04-01	Roth Capital	Maintains	Buy→Buy
2021-04-01	HC Wainwright & Co.	Maintains	Buy→Buy
2021-02-10	HC Wainwright & Co.	Maintains	Buy→Buy
2020-04-01	H.C. Wainwright	Maintains	Buy→Buy
2019-09-26	H.C. Wainwright	Maintains	Buy→Buy
2019-04-18	H.C. Wainwright	Maintains	Buy→Buy
2019-02-14	Maxim Group	Maintains	Buy→Buy
2019-01-25	Roth Capital	Maintains	Buy→Buy
2017-07-24	H.C. Wainwright	Maintains	Buy→Buy

HC Wainwright & Co.2021-08-02

Maintains

Buy→Buy

Roth Capital2021-04-01

Maintains

Buy→Buy

HC Wainwright & Co.2021-04-01

Maintains

Buy→Buy

HC Wainwright & Co.2021-02-10

Maintains

Buy→Buy

H.C. Wainwright2020-04-01

Maintains

Buy→Buy

H.C. Wainwright2019-09-26

Maintains

Buy→Buy

H.C. Wainwright2019-04-18

Maintains

Buy→Buy

Maxim Group2019-02-14

Maintains

Buy→Buy

Roth Capital2019-01-25

Maintains

Buy→Buy

H.C. Wainwright2017-07-24

Maintains

Buy→Buy

Wall Street analysts have recently issued updated ratings on AzurRx BioPharma, Inc. (AZRX) stock. Of the recent 10 rating actions, 0 were upgrades and 0 were downgrades. 4 analysts currently cover AZRX.

Analyst Recommendation Trends

Buy ratings1 → 1

Hold ratings0 → 0

Sell ratings0 → 0

AZRX analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

—

Revenue Next Year

—

EPS This Year

—

EPS Next Year

—

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast AZRX EPS of $— for the current fiscal year, based on estimates from 0 analysts. The AZRX revenue forecast is — for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The AZRX stock forecast is supported by two independent data sources: analyst consensus ratings from 4 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus AZRX price target is $0.00 (+0.0% upside), with an analyst consensus of Buy.

The AZRX short-term stock prediction for tomorrow is $3.28 (-5.00%).

AzurRx BioPharma, Inc. trades on NASDAQ under the ticker AZRX. The AZRX stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Earnings Revenue PE Ratio Financials Market Cap Insider Trades Dividends Price History

Frequently asked questions

AZRX forecast · 8 questions

According to 4 Wall Street analysts, the average 12-month AZRX price target is $0.00, with a high forecast of $0.00 and a low of $0.00. The median price target is shown in the chart above when available. This implies +0.0% potential upside from the current price of $3.45.

AZRX price targetWhat is AZRX price targetAZRX analyst price targetAZRX 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.